J 2020

Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures

TAN, Tiong Yang, Jiří SEDMÍK, Mark P. FITZGERALD, Rivka SUKENIK HALEVY, Liam KEEGAN et. al.

Basic information

Original name

Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures

Authors

TAN, Tiong Yang, Jiří SEDMÍK (203 Czech Republic, belonging to the institution), Mark P. FITZGERALD, Rivka SUKENIK HALEVY, Liam KEEGAN (372 Ireland, belonging to the institution), Ingo HELBIG, Lina BASEL-SALMON, Lior COHEN, Rachel STRAUSSBERG, Wendy K. CHUNG, Mayada HELAL, Reza MAROOFIAN, Henry HOULDEN, Jane JUUSOLA, Simon SADEDIN, Lynn PAIS, Katherine B. HOWELL, Susan M. WHITE, John CHRISTODOULOU and Mary Anne O'CONNELL (372 Ireland, guarantor, belonging to the institution)

Edition

The American Journal of Human Genetics, University of Chicago Press for the American Society of Human Genetics, 2020, 0002-9297

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10608 Biochemistry and molecular biology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 11.025

RIV identification code

RIV/00216224:14740/20:00114081

Organization unit

Central European Institute of Technology

UT WoS

000523306000005

Keywords in English

ADAR2; microcephaly; migrating focal seizures; epilepsy; intellectual disability; RNA editing

Tags

International impact, Reviewed
Změněno: 9/10/2024 12:25, Mgr. Adéla Pešková

Abstract

V originále

The RNA editing enzyme ADAR2 is essential for the recoding of brain transcripts. Impaired ADAR2 editing leads to early-onset epilepsy and premature death in a mouse model. Here, we report bi-allelic variants in ADARB1, the gene encoding ADAR2, in four unrelated individuals with microcephaly, intellectual disability, and epilepsy. In one individual, a homozygous variant in one of the double-stranded RNA-binding domains (dsRBDs) was identified. In the others, variants were situated in or around the deaminase domain. To evaluate the effects of these variants on ADAR2 enzymatic activity, we performed in vitro assays with recombinant proteins in HEK293T cells and ex vivo assays with fibroblasts derived from one of the individuals. We demonstrate that these ADAR2 variants lead to reduced editing activity on a known ADAR2 substrate. We also demonstrate that one variant leads to changes in splicing of ADARB1 transcript isoforms. These findings reinforce the importance of RNA editing in brain development and introduce ADARB1 as a genetic etiology in individuals with intellectual disability, microcephaly, and epilepsy.

Links

GA19-16963S, research and development project
Name: Genetický model myši pro studium kontroly interferonu a zánětu
Investor: Czech Science Foundation
90062, large research infrastructures
Name: Czech-BioImaging